New Issue: HSBC USA prices $0.765 million 18% reverse convertibles linked to Gilead Sciences

By Jennifer Chiou

New York, Aug. 29 - HSBC USA Inc. priced a $0.765 million issue of 18% reverse convertible notes due Nov. 30, 2006 linked to Gilead Sciences, Inc. stock, according to a 424B2 filing with the Securities and Exchange Commission.

Payout at maturity will be par in cash unless Gilead Sciences stock declines by 15% or more during the life of the notes and it finishes below the initial price, in which case investors will receive a number of Gilead Sciences shares equal to $1,000 divided by the initial price.

Issuer:	HSBC USA Inc.
Issue:	Reverse convertible notes
Underlying stock:	Gilead Sciences, Inc.
Amount:	$0.765 million
Maturity:	Nov. 30, 2006
Price:	Par
Coupon:	18%
Payout at maturity:	Par unless Gilead Sciences stock falls by 15% or more during the life of the notes and it finishes below the initial price, in which case a number of Gilead Sciences shares equal to $1,000 divided by the initial price
Initial price:	$63.20
Pricing date:	Aug. 25
Settlement date:	Aug. 31
Agent:	HSBC Securities (USA) Inc.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.